Cor Vasa 2006, 48(10):331-332 | DOI: 10.33678/cor.2006.108

Kardiovaskulární onemocnění a dysfunkce parenchymatózních orgánů

Ondfiej Viklický
Klinika nefrologie, Transplantační centrum, Institut klinické a experimentální medicíny, Praha, Česká republika

Published: October 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Viklický O. Kardiovaskulární onemocnění a dysfunkce parenchymatózních orgánů. Cor Vasa. 2006;48(10):331-332. doi: 10.33678/cor.2006.108.
Download citation

References

  1. Dekker JM, Girman C, Rhodes T, et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Horn Study. Circulation 2005;112:666-73. Go to original source... Go to PubMed...
  2. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New Engl J Med 1997;336: 973-9. Go to original source... Go to PubMed...
  3. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97:425-8. Go to original source... Go to PubMed...
  4. Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 2001;32:2575-9. Go to original source... Go to PubMed...
  5. Tataru M, Heinrich J, Junker R, et al. C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. Eur Heart J 2000;21:1000-8. Go to original source... Go to PubMed...
  6. Puddu P, Cravero E, Puddu GM, Muscari A. Genes and atherosclerosis: at the origin of the predisposition. Int J Clin Pract 2005;59:462-72. Go to original source... Go to PubMed...
  7. Andreotti F, Porto I, Crea F, Maseri A. Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart 2002; 87:107-12. Go to original source... Go to PubMed...
  8. Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ. The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001;22:2243-52. Go to original source... Go to PubMed...
  9. Li JJ, Chen MZ, Chen X, Fang CH. Rapid effects of simvastatin on lipid profile and C-reactive protein in patients with hypercholesterolemia. Clin Cardiol 2003; 26:472-6. Go to original source... Go to PubMed...
  10. Pannaciulli N, Cantatore FP, Minenna A, et al. C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. Int J Obes 2001;25:1416-20. Go to original source... Go to PubMed...
  11. Dvofiáková-Lorenzová A, Suchánek P, Havel PJ, et al. The decrease in C-reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma lipids, but not interleukin-6 or adiponectin. Metabolism 2006;55:359-65. Go to original source... Go to PubMed...
  12. Zee RYL, Ridker PM. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 2002;162:217-9. Go to original source...
  13. Suk JH, Ridker PM, Cook NR, Zee RYL. Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis 2005;178:139-45. Go to original source... Go to PubMed...
  14. Asztalos BF, Collins DM, Cupples LA, et al. Value of High-Density Lipoprotein (HDL) Subpopulations in Predicting Recurrent Cardiovascular Events in the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vasc Biol 2005;25:2185-91. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.